Anti-CD38 Antibody Treating APS With Thrombocytopenia
NCT05983952
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Antiphospholipid Syndrome
Thrombocytopenia
Interventions
DRUG:
Anti-CD38 antibody Injection
Sponsor
Institute of Hematology & Blood Diseases Hospital, China